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Abstract 
Using isoelectric focusing (lEE) and radial immunodiffusion (RID) techniques, serum samples from
100 normal healthy adults and 21 patients with pulmonary emphysema were analysed to identify
varioud alpha 1 antitrypsin phenotypes and the Seru m concentrations,Ten percent of the patients had
low serum values. The normal or most common genetic form, MM, is the predominant phenotype in
both controls and patients (JPMA 46:102, 1996).
Introduction 
Emphysema is generally defined as an anatomical disorder of the lungs characterized by increase
beyond the normal in the size of the air spaces distal to the terminal bronchioles with destructive
changes in their walls. Chronic bronchitis is mostly associated with it. Together, they form chronic
airway obstructive disease.
Protease - antiprotease imbalance plays a major role in the development of emphysema1. Elastase, a
serine protease has the ability to cleave native elastin2. Inflammation in the lung results in the release
of elastase, which in the tissue is inactivated by complex formation with the protease inhibitors3. Alpha
1 antitry psin (alpha 1 AT)is the most potent serine protease inhibitor. It’s primary site of action is the
lower respiratory tract, where it protects the alveolar walls against destruction4. Normally, the
inactivation of elastase is so efficient that no activity is left in the pulmonary tissue5. However,
deficiency of alpha 1 AT may leave some of the elastase uninhibited, resulting in destruction of the
elastic tissue in the alveolar wall and subsequent development of emphysema of the lungs. Apart from
alpha 1 AT deficiency, other factois such as cigarette smoking, asthma, lower respiratory tract
infections contribute to the serious clinical course6,7.
This study was undertaken to determine the serum concentmtion and to identify the various alpha 1 AT
phenotypes in the local population, comprising of healthy subjects and patients with emphysema.
Patients and Methods 
Twenty-one patients with pulmonary emphysema and one hundred healthy adults, with no history of
pulmonary disease were selected for the study.
Patients complaining of dyspnoea on exertion, were subjected to physical examination, Those with
increased percusion note and reduced air entry in both lungs with signs of airway obstruction wern x-
rayed. The patients with flattened or low diaphragm, hyperlucent lung fields with diminished lung
markings with or without bullae had spirometry and only those with compromised lung function not
reversible after bronchodilators were included in the study. No arterial blood gases were done. Most of
the patients were either smokers orex-smokers.
Patients age varied from 7-70 years, with a mean age of 48.5 years (median: 41 years). There were 20
males and 1 female. In the control group the age range was 18-82 years (mean age: 33.4 years). There
were 52 males and 48 females.
All sera were stored at -70°C until analysed.
Quantitative measurement of senun alpha 1 AT was camed out by single radial immunodiffusion (RID)
technique using M partigen immunodiffusion plates (Behring Diagnostic, MaEburg, Germany).
Phenotyping was performed by ultra thin layerpolyacrylamide gel isoelectric focusing (IEF), using gels
containing 2% ampholytes in the pH range 4.2-4.9. Further corifinnation of alpha 1 AT phenotypes was
done by immunofixation9.
Results 
The mean value of serum alpha 1 AT concentration in healthy subjects was 2.47+0.08 g/f (range: 0.52-
5.0 gil) and in patients with pulmonaiy emphysema 2.68+0.14 g/1 (range: 1.46-3.95 g/l). Amongst the
control, mean serum alpha 1 ATmn non-smokers was 2.56+0.075 g/l (range:1.46-5.O g/1), whereas in
smokers the mean serum concentration was 2.1+0.21 g/l (mnge: 0.52-3.95 g/l). It was observed that
13% of the control subjects and 10% of the patients manifested low levels. Any value of less than 2.0
g/l was considered as lower than normal. But these low levels appear to have no diagnostic significance
as none of these sera exhibited abnormal patterns when subjected to IEF.
Isoelectric focusing is now considered as a procedure of choice in evaluating the various phenotypes
and evolves a more correct assessment of serum alpha 1 AT levels in normal population as well as in
disease conditions.
Figure represents a typical pattern of alpha 1 AT on IEF. Seventy percent of healthy subjects have a
phenotype resembling MM, followed byM 1M2(28%) and FM3 (2%). Inpatientswithemphysema also
MMwas predominant followed by Ml M2.
Discussion 
Alpha 1 antitrypsin deficiency is the most common genetic cause of emphysema in adults and liver
disease in children10. Although a severe deficiency is clearly a risk factor forthe development of
emphysema, most individuals with the said disease have normal serum concentrationof this anti-
elastase11. In the present study, serum concentrations were lower than normal values in 10% of the
patients, but they too had the normal phenotype M. Clinical findings also show that there was no
difference between the patients manifesting low concentmtions versus those with normal values. It is
the phenotype and not the serum concentration alone that is apparently of some importance in
predisposing to lung disease. Persons who are PI type M and yet have moderately reduced
concentrations of alpha 1 AT, probably have ample reserve capacity to increase their alpha 1 AT
concentration during times of infection, when morn alpha 1 AT might be required to protect the lungs
from proteolysis. The Z gene product apparently cannot respond with increased production. The
increased risk for heterozygotes of PI MZ could be due to this lack of response of the Z allele or to
some other effect of the abnormal Z protein in circulation12,13.
For most peopie, it is cigarette smoking and not severe alpha 1 AT deficiency, that is the major risk
factor for the development of emphysema14. The present observations accords with the findings of
others where most of the patients had a histoiy of smoking.
Exposure of the lungs to tobacco smoke markedly increases the number of pulmonary alveolar
macmphages which become activated to give increased proteolytic activity and also to secrete a
chemotactic factor which attract leucocytes to the lung15. There is an increase in the elastolytic load in
the lungs and at the same time the inhibitory activity of alpha 1 AT in the alveoli greatly decreases16.
This decrease is the result of direct oxidation of its reactive centre by free radicals in the smoke17 and
also by oxygen radicals released from the activated leucocytes18. This increased production of elastase,
together with a decrease in inhibitory activity, results ‘in an attack on the elastic tissue of the lower
respiratory tract and the development of emphysema19.
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